Literature DB >> 11067899

IFN-gamma and IFN-alpha posttranscriptionally down-regulate the IL-4-induced IL-4 receptor gene expression.

E Y So1, H H Park, C E Lee.   

Abstract

As Th1 and Th2 cytokines, IFN-gamma/alpha and IL-4 counterregulate diverse immune functions. In particular, IFN-gamma and IFN-alpha have been reported to markedly suppress the IL-4-induced IgE production and type II IgE receptor (FcepsilonRII/CD23) expression. Because modulation of IL-4R may be an important mechanism in the regulation of IL-4 response, we have investigated the effect of IFN-gamma/alpha on IL-4R expression and signal transduction mechanisms involved in this process. In human mononuclear cells and B cells isolated from tonsil or peripheral blood, IL-4 up-regulates IL-4R(alpha) expression at surface protein and mRNA levels, and the IL-4-induced IL-4R(alpha) is significantly down-regulated by both IFN-gamma and IFN-alpha to a similar extent. The inhibitory effects of IFN-gamma/alpha on the IL-4R mRNA expression require a lag period of about 8 h, and are sensitive to cycloheximide treatment, which suggests that the suppressive effect of IFNs on IL-4R gene expression is a secondary response requiring de novo synthesis of IFN-induced factors. Under such conditions that the inhibitory effects of IFNs are observed, IFNs do not affect the IL-4-induced STAT6 activation and IL-4R transcription, as analyzed by EMSA and nuclear run-on assays, respectively. Subsequently, mRNA stability studies have indicated that the action of IFN-gamma/alpha is primarily mediated by an accelerated decay of IL-4-induced IL-4R mRNA. Thus, it appears that, as already shown in the case of the IL-4-induced FcepsilonRII regulation, posttranscriptional inhibition of IL-4-inducible genes by mRNA destabilization is a common mechanism by which type I and II IFNs antagonize the IL-4 response in human immune cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067899     DOI: 10.4049/jimmunol.165.10.5472

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  A point of view: HIV-1/AIDS is an allergy but CpG ODN treatments may inhibit virus replication and reactivate the adaptive immunity--hypothesis and implications.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

2.  Does Fasciola hepatica infection modify the response of acute hepatitis C virus infection to IFN-alpha treatment?

Authors:  Mehmet Sahin; Mehmet Isler; Altug Senol; Mustafa Demirci; Zeynep Dilek Aydin
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

3.  Changes in immune responses to antigen applied to tape-stripped skin with CpG-oligodeoxynucleotide in NC/Nga mice.

Authors:  Joe Inoue; Satoshi Yotsumoto; Takatoshi Sakamoto; Seishi Tsuchiya; Yukihiko Aramaki
Journal:  Pharm Res       Date:  2005-09-26       Impact factor: 4.200

4.  IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells.

Authors:  Jonathan P Huber; Sarah R Gonzales-van Horn; Kole T Roybal; Michelle A Gill; J David Farrar
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

5.  Regulation of eotaxin-3/CCL26 expression in human monocytic cells.

Authors:  Victoria E L Stubbs; Christopher Power; Kamala D Patel
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

Review 6.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

7.  Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics.

Authors:  Ahmad R Sedaghat; Jennifer German; Tanya M Teslovich; Joseph Cofrancesco; Chunfa C Jie; C Conover Talbot; Robert F Siliciano
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

8.  Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells.

Authors:  Claire Hastie; John R Masters; Stephen E Moss; Soren Naaby-Hansen
Journal:  J Biol Chem       Date:  2008-01-22       Impact factor: 5.157

9.  MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.

Authors:  Xiaorong Zhou; Yang Jiang; Liming Lu; Qing Ding; Zhijun Jiao; Yun Zhou; Lijun Xin; Kuang-Yen Chou
Journal:  Immunology       Date:  2007-07-20       Impact factor: 7.397

Review 10.  Molecular mechanisms of the anti-inflammatory functions of interferons.

Authors:  Pavel Kovarik; Ines Sauer; Barbara Schaljo
Journal:  Immunobiology       Date:  2007-11-08       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.